FDA-approved GLP-1 medications are administered via subcutaneous injection (semaglutide, liraglutide, dulaglutide, tirzepatide) into the abdomen, thigh, or upper arm, or taken orally as Rybelsus
Sermorelin binds to GHRH receptors in the pituitary gland, prompting it to produce and secrete growth hormone in a natural, pulsatile pattern
Montserrat et al., 2004
After helping clients through structured titration plans for 12 weeks , a clear pattern appeared: starting low, staying at each tolerated step for the recommended time, and keeping track of symptoms leads to fewer early dropouts and more steady fat loss
Supplementary Video 2 Partial unbinding and binding simulation of Ex4
Tirzepatide, the powerful dual GLP-1 and GIP receptor agonist, works by reducing hunger, improving insulin sensitivity, and promoting significant fat lossmaking it one of the most effective weight loss medications available